Tarsus Pharmaceuticals (TARS) News Today → I’m officially sounding the alarm. (From Altimetry) (Ad) Free TARS Stock Alerts $33.05 +0.20 (+0.61%) (As of 09:56 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineInsider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%finance.yahoo.com - April 19 at 8:16 AMQ1 2024 EPS Estimates for Tarsus Pharmaceuticals, Inc. Boosted by Analyst (NASDAQ:TARS)marketbeat.com - April 19 at 8:16 AMTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Rating of "Moderate Buy" from Brokeragesamericanbankingnews.com - April 18 at 2:14 AMTarsus Pharmaceuticals (NASDAQ:TARS) Shares Down 5.2% americanbankingnews.com - April 14 at 4:42 AMVanguard Group Inc. Has $27.58 Million Stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)marketbeat.com - April 13 at 4:30 AMTarsus Pharmaceuticals (NASDAQ:TARS) Trading Down 5.2%marketbeat.com - April 12 at 2:51 PMTarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Up 6.1%marketbeat.com - April 11 at 4:01 PMWall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Knowfinance.yahoo.com - April 8 at 2:09 PMScientists share trial results for new tick-repelling drug for humans: 'An amazing opportunity'msn.com - April 6 at 2:18 AMTarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Up 6.3%marketbeat.com - March 28 at 7:27 PMTarsus Pharmaceuticals executive sells over $130k in company stockinvesting.com - March 21 at 8:19 PMTarsus Pharmaceuticals exec sells over $135k in stockinvesting.com - March 21 at 8:19 PMBryan Wahl Sells 4,436 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Stockinsidertrades.com - March 20 at 6:52 AMInsider Selling: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) General Counsel Sells 4,436 Shares of Stockmarketbeat.com - March 19 at 8:14 PMPill Targeting Tick-Induced Lyme Disease Shows Promise in Human Trialsmsn.com - March 18 at 2:35 AMTARS Apr 2024 25.000 callfinance.yahoo.com - March 16 at 2:01 PMTARS Apr 2024 17.500 putfinance.yahoo.com - March 16 at 1:17 AMTARS Apr 2024 12.500 callfinance.yahoo.com - March 16 at 1:17 AMTarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 6.9%marketbeat.com - March 15 at 12:37 PMAnalysts Offer Insights on Healthcare Companies: ProQR (PRQR) and Crinetics Pharmaceuticals (CRNX)markets.businessinsider.com - March 13 at 7:29 PMTarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Down 5.7%marketbeat.com - March 11 at 12:44 PMTarsus Pharmaceuticals (NASDAQ:TARS) Price Target Increased to $44.00 by Analysts at Jefferies Financial Groupmarketbeat.com - March 7 at 8:20 AMRTW Investments LP Grows Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)marketbeat.com - March 6 at 11:00 AMTarsus to Participate at Upcoming Investor Conferencesglobenewswire.com - March 5 at 4:30 PMTarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitisglobenewswire.com - March 5 at 8:30 AMConnor Clark & Lunn Investment Management Ltd. Makes New Investment in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)marketbeat.com - March 4 at 6:02 AMTarsus Pharmaceuticals (NASDAQ:TARS) Sees Unusually-High Trading Volume Following Analyst Upgrademarketbeat.com - March 3 at 1:03 AMTarsus Pharmaceuticals launches $100 million stock offeringinvesting.com - March 2 at 8:15 AMTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting Their Estimatesfinance.yahoo.com - March 1 at 5:07 PMTarsus Pharmaceuticals (NASDAQ:TARS) Sees Large Volume Increase on Analyst Upgrademarketbeat.com - March 1 at 10:15 AMTarsus Pharmaceuticals stock dips after pricing $100M securities offeringmsn.com - March 1 at 7:05 AMTarsus Pharmaceuticals Shares Slip Premarket After Stock Offeringmarketwatch.com - March 1 at 7:05 AMQ1 2024 EPS Estimates for Tarsus Pharmaceuticals, Inc. Raised by Analyst (NASDAQ:TARS)marketbeat.com - March 1 at 6:36 AMTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Acquired by Swiss National Bankmarketbeat.com - March 1 at 4:17 AMTarsus Announces Pricing of $100.0 Million Public Offeringglobenewswire.com - March 1 at 12:07 AMTarsus Pharmaceuticals, Inc. (TARS) Q4 2023 Earnings Call Transcriptseekingalpha.com - February 29 at 10:48 PMTarsus Pharmaceuticals Shares Fall 11% After Public Offering Newsmarketwatch.com - February 29 at 10:48 PMTarsus announces proposed $100M public offeringmsn.com - February 29 at 5:47 PMTarsus Announces Proposed $100.0 Million Public Offeringglobenewswire.com - February 29 at 4:37 PMTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Forecasted to Post Q1 2025 Earnings of ($1.36) Per Sharemarketbeat.com - February 29 at 8:53 AMParty Time: Brokers Just Made Major Increases To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Earnings Forecastsfinance.yahoo.com - February 29 at 7:47 AMBuy Rating Affirmed: Tarsus Pharmaceuticals’ Strong Q4 and Robust Pipeline Fuel Upward Price Revisionmarkets.businessinsider.com - February 28 at 1:08 PMTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 28 at 1:08 PMTarsus Pharmaceuticals (NASDAQ:TARS) Announces Earnings Results, Beats Expectations By $0.06 EPSmarketbeat.com - February 28 at 10:42 AMTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Rating of "Moderate Buy" by Brokeragesmarketbeat.com - February 28 at 9:46 AMTarsus Pharmaceuticals (NASDAQ:TARS) Stock Rating Reaffirmed by Oppenheimermarketbeat.com - February 28 at 8:30 AMTarsus Pharmaceuticals Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - February 28 at 8:08 AMQ4 2023 Tarsus Pharmaceuticals Inc Earnings Callfinance.yahoo.com - February 28 at 1:41 AMTarsus Pharmaceuticals Shares Rise 13% On Product Salesmarketwatch.com - February 27 at 3:41 PMTarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Up to $33.16marketbeat.com - February 27 at 11:48 AM Get Tarsus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TARS and its competitors with MarketBeat's FREE daily newsletter. Email Address I’m officially sounding the alarm. (Ad)AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone. Just click here to watch my full uncensored interview. TARS Media Mentions By Week TARS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TARS News Sentiment▼0.840.52▲Average Medical News Sentiment TARS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TARS Articles This Week▼73▲TARS Articles Average Week Get Tarsus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TARS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vir Biotechnology News Autolus Therapeutics News Scholar Rock News Adaptimmune Therapeutics News 4D Molecular Therapeutics News Kyverna Therapeutics News ADMA Biologics News BioCryst Pharmaceuticals News Relay Therapeutics News Immatics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TARS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden’s $374B Giveaway Into This SectorDTIThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.